BioMed Central | Members | Shenzhen Beike BioTech

Submit a manuscript Register Contact us

Institution search

Search by institution name/city

Members

Australia (21)
Austria (6)
Belgium (3)
Brazil (4)
Burkina Faso (1)
Canada (25)
Central African Republic (1)
China (3)
Cyprus (3)
Czech Republic (1)
Denmark (2)
Ethiopia (1)
Finland (6)
France (7)
Germany (51)
Ghana (3)
Greece (1)
Hong Kong (2)
Hungary (1)
India (8)
Ireland (1)
Israel (1)
Italy (16)
Kenya (3)
Korea, South (2)
Lebanon (1)
Lithuania (2)
Luxembourg (1)
Madagascar (1)
Malaysia (4)
Mexico (1)
Morocco (2)
Netherlands (11)
New Zealand (1)
Nigeria (2)
Norway (4)
Poland (2)
Portugal (1)
Romania (1)
South Africa (6)
Spain (13)
Sri Lanka (2)
Sweden (9)
Switzerland (10)
Taiwan (3)
Tanzania (3)
Thailand (1)
Trinidad and Tobago (1)
Uganda (1)
United Kingdom (49)
United States of America (159)

Advertisement

Member - Shenzhen Beike BioTech

Shenzhen Beike Biotechnology Co., Ltd. (Beike Biotechnology) is a leading Chinese biotechnology company based in Shenzhen China. Beike Biotechnology specializes in research, clinical translation and technology support services in the adult stem cell field. The company was founded in 2005 with capital from Beijing University, Hong Kong University of Science and Technology and Shenzhen City Hall, with additional support from China State National Fund grants.

Research staff and students at Shenzhen Beike BioTech:

Do you realize that you can now publish in journals published by BioMed Central without directly paying any article-processing charges? Payment of your article-processing charges is covered by Shenzhen Beike BioTech's Prepay Membership. Read more information about publishing your articles with us.

Work published with BioMed Central, Chemistry Central and SpringerOpen by researchers at Shenzhen Beike BioTech

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	1.	Research Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism Yong-Tao Lv, Yun Zhang, Min Liu, Jia-na-ti Qiuwaxi, Paul Ashwood, Sungho Cho, Ying Huan, Ru-Cun Ge, Xing-Wang Chen, Zhao-Jing Wang, Byung-Jo Kim, Xiang Hu Journal of Translational Medicine 2013, 11:196 (27 August 2013) Abstract \| Full text \| PDF \| PubMed
	2.	Case report Human cord blood-derived mononuclear cell transplantation for viral encephalitis-associated cognitive impairment: a case report Wan-Zhang Yang, Guo-Jian Shu, Yun Zhang, Fang Wu, Bi-Yu Ye, Xiang Hu Journal of Medical Case Reports 2013, 7:181 (8 July 2013) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary Remarkable neuropsychiatric and neurobehavioral recovery following human cord blood-derived mononuclear cell transplantation
	3.	Research article Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson’s disease Xiao Wang, Gang Lu, Xiang Hu, Kam Tsang, Wing Kwong, Feng Wu, Hai Meng, Shu Jiang, Shu Liu, Ho Ng, Wai Poon BMC Neuroscience 2012, 13:142 (14 November 2012) Abstract \| Full text \| PDF \| PubMed
	4.	Research Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with Hereditary Ataxia Wan-Zhang Yang, Yun Zhang, Fang Wu, Min Zhang, SC Cho, Chun-Zhen Li, Shao-Hui Li, Guo-Jian Shu, You-Xiang Sheng, Ning Zhao, Ying Tang, Shu Jiang, Shan Jiang, Matthew Gandjian, Thomas E Ichim, Xiang Hu Journal of Translational Medicine 2011, 9:65 (16 May 2011) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	5.	Research Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions Wan-Zhang Yang, Yun Zhang, Fang Wu, Wei-Ping Min, Boris Minev, Min Zhang, Xiao-Ling Luo, Famela Ramos, Thomas E Ichim, Neil H Riordan, Xiang Hu Journal of Translational Medicine 2010, 8:75 (3 August 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central